Particle engineering of a needle-like active pharmaceutical ingredient into size controlled agglomerates: Part II. Evaluating direct compression manufacturability, microstructure and product performance

Bilal Ahmed, Nobuaki Kishimoto, Jun Wang, Marianne Langston, Yihui Yang, Shijie Zhang, Juliette Ho, Prajakta Gadgil, Aidan Herbert, Kenneth Smith

Open source

DOI
10.1016/j.ijpharm.2026.126637
Published
2026-03
Container
International Journal of Pharmaceutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.126637,
  title = {Particle engineering of a needle-like active pharmaceutical ingredient into size controlled agglomerates: Part II. Evaluating direct compression manufacturability, microstructure and product performance},
  author = {Bilal Ahmed and Nobuaki Kishimoto and Jun Wang and Marianne Langston and Yihui Yang and Shijie Zhang and Juliette Ho and Prajakta Gadgil and Aidan Herbert and Kenneth Smith},
  year = {2026},
  journal = {International Journal of Pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.126637},
  url = {https://doi.org/10.1016/j.ijpharm.2026.126637}
}

RIS

TY  - JOUR
TI  - Particle engineering of a needle-like active pharmaceutical ingredient into size controlled agglomerates: Part II. Evaluating direct compression manufacturability, microstructure and product performance
AU  - Bilal Ahmed
AU  - Nobuaki Kishimoto
AU  - Jun Wang
AU  - Marianne Langston
AU  - Yihui Yang
AU  - Shijie Zhang
AU  - Juliette Ho
AU  - Prajakta Gadgil
AU  - Aidan Herbert
AU  - Kenneth Smith
PY  - 2026
JO  - International Journal of Pharmaceutics
DO  - 10.1016/j.ijpharm.2026.126637
UR  - https://doi.org/10.1016/j.ijpharm.2026.126637
ER  - 

APA

Ahmed, B., Kishimoto, N., Wang, J., Langston, M., Yang, Y., Zhang, S., Ho, J., Gadgil, P., Herbert, A., & Smith, K. (2026). Particle engineering of a needle-like active pharmaceutical ingredient into size controlled agglomerates: Part II. Evaluating direct compression manufacturability, microstructure and product performance. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.126637

Source records